Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Evoke Pharma Inc

EVOK
Current price
5.65 USD -0.22 USD (-3.75%)
Last closed 5.65 USD
ISIN US30049G2030
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 4 751 778 USD
Yield for 12 month -63.22 %
1Y
3Y
5Y
10Y
15Y
EVOK
21.11.2021 - 28.11.2021

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California. Address: 420 Stevens Avenue, Solana Beach, CA, United States, 92075

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

18 USD

P/E ratio

Dividend Yield

Current Year

+5 180 630 USD

Last Year

+2 508 645 USD

Current Quarter

+2 551 366 USD

Last Quarter

+1 735 490 USD

Current Year

+4 978 751 USD

Last Year

+2 138 251 USD

Current Quarter

+2 509 888 USD

Last Quarter

+1 642 961 USD

Key Figures EVOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA
Operating Margin TTM -47.96 %
PE Ratio
Return On Assets TTM -36.8 %
PEG Ratio -0.1
Return On Equity TTM -407.6 %
Wall Street Target Price 18 USD
Revenue TTM 7 525 709 USD
Book Value 3.63 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 125.5 %
Dividend Yield
Gross Profit TTM 2 138 251 USD
Earnings per share -15.89 USD
Diluted Eps TTM -15.89 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -86.75 %

Dividend Analytics EVOK

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History EVOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 01.08.2024
Dividend Date

Stock Valuation EVOK

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.0763
Price Sales TTM 0.6314
Enterprise Value EBITDA -0.3555
Price Book MRQ 1.7831

Financials EVOK

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators EVOK

For 52 weeks

3.54 USD 17.88 USD
50 Day MA 4.91 USD
Shares Short Prior Month 93 854
200 Day MA 6.18 USD
Short Ratio 0.65
Shares Short 25 992
Short Percent 3.2 %